Eclipse Life Sciences begins phase 2 study for novel ophthalmology steroid implant for diabetic macular edema: Research Triangle Park, North Carolina Tuesday, April 14, 2026, 18:0 ...
Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company focused on the development of novel therapies for ophthalmic diseases, today announced that it has completed ...
The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results